Reversible coma in children after improper baclofen pump insertion
KEITH J. ANDERSON FRCA
Department of Pediatric Anaesthesia, Neurosurgery and Oncology Montreal Childrens' Hospital, McGill University Healthcare Center, Montreal, Quebec, Canada,
Search for more papers by this authorJEAN-PIERRE FARMER FRCP (Canada)
Department of Neurology, Neurosurgery and Oncology Montreal Childrens' Hospital, McGill University Healthcare Center, Montreal, Quebec, Canada
Search for more papers by this authorKAREN BROWN FRCP (Canada)
Department of Pediatric Anaesthesia, Neurosurgery and Oncology Montreal Childrens' Hospital, McGill University Healthcare Center, Montreal, Quebec, Canada,
Search for more papers by this authorKEITH J. ANDERSON FRCA
Department of Pediatric Anaesthesia, Neurosurgery and Oncology Montreal Childrens' Hospital, McGill University Healthcare Center, Montreal, Quebec, Canada,
Search for more papers by this authorJEAN-PIERRE FARMER FRCP (Canada)
Department of Neurology, Neurosurgery and Oncology Montreal Childrens' Hospital, McGill University Healthcare Center, Montreal, Quebec, Canada
Search for more papers by this authorKAREN BROWN FRCP (Canada)
Department of Pediatric Anaesthesia, Neurosurgery and Oncology Montreal Childrens' Hospital, McGill University Healthcare Center, Montreal, Quebec, Canada,
Search for more papers by this authorAbstract
We report the occurrence of delayed postoperative coma in five of nine consecutive children following surgery for insertion of baclofen infusion pumps. We suspect that improper technique resulted in an inadvertent administration of an intrathecal baclofen bolus. We suggest ways to minimize this risk.
References
- 1 Nolan J, Chalkiadis GA, Low J et al. Anaesthesia and pain management in cerebral palsy. Anaesthesia 2000; 55 : 32–41.
- 2 Albright AL. Baclofen in the treatment of cerebral palsy. J Child Neurol 1996; 11 : 77–83.
- 3 Albright AL, Schultz BL. Plasma baclofen levels in children receiving continuous intrathecal baclofen infusion. J Child Neurol 1999; 44 : 408–409.
- 4 Albright AL. Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 1996; 11 : S29–S35.
- 5 Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964; 192 : 540–542.
- 6 Butler C, Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Dev Med Child Neurol 2000; 42 : 634–645.DOI: 10.1017/s0012162200001183
- 7 Albright AL, Barry MJ, Fasick MP et al. Effects of continuous intrathecal baclofen infusion and selective posterior rhizotomy on upper extremity spasticity. Pediatr Neurosurg 1995; 23 : 82–85.
- 8 Albright AL, Barry MJ, Painter MJ et al. Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy. J Neurosurg 1998; 88 : 73–76.
- 9 Gerszten PC, Albright AL, Barry MJ. Effect on ambulation of continuous intrathecal baclofen infusion. Pediatr Neurosurg 1997; 27 : 40–44.
- 10 Albright AL, Barron WB, Fasick MP et al. Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 1993; 270 : 2475–2477.
- 11 Gertzen PC, Albright AL, Johnstone GF. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 1998; 88 : 1009–1013.
- 12 Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA 1991; 265 : 1418–1422.
- 13 Gilmartin R, Bruce D, Storrs BB et al. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial. J Child Neurol 2000; 15 : 71–77.
- 14 Armstrong RW, Steinbok P, Cochrane DD et al. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 1997; 87 : 409–414.
- 15 Novartis Pharmaceuticals. Intrathecal Lioresal (baclofen) – product data sheet. Compendium of Pharmaceuticals and Specialties, 35th edn. Novartis Pharmaceuticals: 2000: 847–849.
- 16 Dressnandt J, Weinzieri FX, Tolle TR et al. Acute intrathecal dose of intrathecal baclofen. J Neurol 1996; 243 : 482–493.
- 17 Perry HE, Wright RO, Shannon MW et al. Baclofen overdose: drug experimentation in a group of adolescents. Pediatrics 1998; 101 : 1045–1048.
- 18 Biavati MJ, Manning SC, Phillips DL. Predictive factors for respiratory complications after tonsillectomy and adenoidectomy in children. Arch Otolaryngol Head Neck Surg 1997; 123 : 517–521.
- 19 Belelli D, Pistis M, Peters JA et al. General anaesthetic action at transmitter gated inhibitory amino acid receptors. Trends Pharmacol Sci 1999; 20 : 496–502.
- 20 Lees G. Molecular mechanisms of anaesthesia: light at the end of the channel? Br J Anaesth 1998; 81 : 491–493.
- 21 Panerai AE, Massei R, De Silva E et al. Baclofen prolongs the analgesic effect of fentanyl in man. Br J Anaesth 1985; 57 : 954–955.
- 22 Gordon NC, Gear RW, Heller PH et al. Enhancement of morphine analgesia by the GABAB agonist baclofen. Neuroscience 1995; 69 : 345–349.DOI: 10.1016/0306-4522(95)00335-G
- 23 Soliman IE, Park TS, Berkelhamer C. Transient paralysis after intrathecal bolus of baclofen for the treatment of post-selective dorsal rhizotomy pain in children. Anesth Analg 1999; 89 : 1233–1235.
- 24 Davidoff RA. Antispasticity drugs: mechanisms of action. Ann Neurol 1985; 17 : 107–116.
Citing Literature
